Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-017-2134-x
Published Online: 2017-08-30
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
den Broeder, Alfons A.
Verhoef, Lise M.
Fransen, Jaap
Thurlings, Rogier
van den Bemt, Bart J. F.
Teerenstra, Steven
Boers, Nadine
den Broeder, Nathan
van den Hoogen, Frank H. J.
Funding for this research was provided by:
CZ innovation fund (201600033)
MENZIS
